CD44, a cell surface glycoprotein that functions as a receptor for hyaluronic acid (HA), a component of the extracellular matrix (ECM), has been identified as a cancer stem cell marker in many cancer types, including breast, brain, prostate, and HNSCC [2–5]. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.